Valproate (VPA) and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches. They are useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. They can be given intravenously or by mouth, and the tablet forms exist in both long- and short-acting formulations.
Genemedi produces core diagnostic ingredients for test of Epilepsy and related syndrome.
GeneMedi offers Diagnostic hapten-carrier conjugates BSA-Sodium valproate (VPA), OVA-Sodium valproate (VPA), KLH-Sodium valproate (VPA) for Epilepsy VPA detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Epilepsy test are suitable for in functional ELISA, and other immunoassays in dignostics.
Order information
Description
|
Cat No.
|
GMP-SMT-VPA-Ag |
|
Product Name
|
BSA-Sodium valproate (VPA) |
|
Expression platform
|
Synthetic |
| Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Sodium valproate (VPA) with anti-Hapten antibody |
| Purity | High (TBD) |
| Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
|
Cat No.
|
GMP-SMT-VPA-Ab-1; GMP-SMT-VPA-Ab-2 |
|
Product Name
|
Anti- Sodium valproate (VPA) mouse monoclonal antibody (mAb) |
|
Expression platform
|
Hybridoma |
| Isotypes | Mouse IgG |
| Bioactivity validation | human Sodium valproate (VPA) binding,
Competitive immunoassay validation (Competitive ELISA) in VPA level test and Epilepsy evaluation. |
| Tag | mFc |
| Products description | Anti- Sodium valproate (VPA) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. |
| Specics | mouse |
| Purity | Purity: ≥95% （SDS-PAGE） |
| Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Facebook
LinkedIn
Twitter
